Literature DB >> 25037503

The pentose phosphate pathway and cancer.

Krushna C Patra1, Nissim Hay2.   

Abstract

The pentose phosphate pathway (PPP), which branches from glycolysis at the first committed step of glucose metabolism, is required for the synthesis of ribonucleotides and is a major source of NADPH. NADPH is required for and consumed during fatty acid synthesis and the scavenging of reactive oxygen species (ROS). Therefore, the PPP plays a pivotal role in helping glycolytic cancer cells to meet their anabolic demands and combat oxidative stress. Recently, several neoplastic lesions were shown to have evolved to facilitate the flux of glucose into the PPP. This review summarizes the fundamental functions of the PPP, its regulation in cancer cells, and its importance in cancer cell metabolism and survival.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25037503      PMCID: PMC4329227          DOI: 10.1016/j.tibs.2014.06.005

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  75 in total

1.  AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress.

Authors:  Sang-Min Jeon; Navdeep S Chandel; Nissim Hay
Journal:  Nature       Date:  2012-05-09       Impact factor: 49.962

2.  Rat liver glucose 6-phosphate dehydrogenase. Regulation by carbohydrate diet and insulin.

Authors:  D Rudack; E M Chisholm; D Holten
Journal:  J Biol Chem       Date:  1971-03-10       Impact factor: 5.157

3.  Subunit interactions of glucose-6-phosphate dehydrogenase from human erythrocytes.

Authors:  P Cohen; M A Rosemeyer
Journal:  Eur J Biochem       Date:  1969-03

4.  Multiple molecular forms of glucose-6-phosphate dehydrogenase in normal, preneoplastic, and neoplastic mammary tissues of mice.

Authors:  R Hilf; R Ickowicz; J C Bartley; S Abraham
Journal:  Cancer Res       Date:  1975-08       Impact factor: 12.701

5.  Regulation of KEAP1 expression by promoter methylation in malignant gliomas and association with patient's outcome.

Authors:  Lucia Anna Muscarella; Raffaela Barbano; Vincenzo D'Angelo; Massimiliano Copetti; Michelina Coco; Teresa Balsamo; Annamaria la Torre; Angelo Notarangelo; Michele Troiano; Salvatore Parisi; Nadia Icolaro; Domenico Catapano; Vanna Maria Valori; Fabio Pellegrini; Giuseppe Merla; Massimo Carella; Vito Michele Fazio; Paola Parrella
Journal:  Epigenetics       Date:  2011-03-01       Impact factor: 4.528

6.  Glycolytic cancer cells lacking 6-phosphogluconate dehydrogenase metabolize glucose to induce senescence.

Authors:  Vikas P Sukhatme; Barden Chan
Journal:  FEBS Lett       Date:  2012-06-04       Impact factor: 4.124

7.  Metabolomic changes accompanying transformation and acquisition of metastatic potential in a syngeneic mouse mammary tumor model.

Authors:  Xin Lu; Bryson Bennet; Euphemia Mu; Joshua Rabinowitz; Yibin Kang
Journal:  J Biol Chem       Date:  2010-02-05       Impact factor: 5.157

8.  The role of NADPH in the regulation of glucose-6-phosphate and 6-phosphogluconate dehydrogenases in rat adipose tissue.

Authors:  A Ayala; I Fabregat; A Machado
Journal:  Mol Cell Biochem       Date:  1991-06-26       Impact factor: 3.396

9.  The dark face of AMPK as an essential tumor promoter.

Authors:  Sang-Min Jeon; Nissim Hay
Journal:  Cell Logist       Date:  2012-10-01

10.  Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted.

Authors:  S Langbein; M Zerilli; A Zur Hausen; W Staiger; K Rensch-Boschert; N Lukan; J Popa; M P Ternullo; A Steidler; C Weiss; R Grobholz; F Willeke; P Alken; G Stassi; P Schubert; J F Coy
Journal:  Br J Cancer       Date:  2006-02-27       Impact factor: 7.640

View more
  398 in total

Review 1.  Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?

Authors:  Nissim Hay
Journal:  Nat Rev Cancer       Date:  2016-09-16       Impact factor: 60.716

Review 2.  Metabolic control of epigenetics in cancer.

Authors:  Adam Kinnaird; Steven Zhao; Kathryn E Wellen; Evangelos D Michelakis
Journal:  Nat Rev Cancer       Date:  2016-09-16       Impact factor: 60.716

3.  ATM couples replication stress and metabolic reprogramming during cellular senescence.

Authors:  Katherine M Aird; Andrew J Worth; Nathaniel W Snyder; Joyce V Lee; Sharanya Sivanand; Qin Liu; Ian A Blair; Kathryn E Wellen; Rugang Zhang
Journal:  Cell Rep       Date:  2015-04-30       Impact factor: 9.423

Review 4.  Role of PKM2 in directing the metabolic fate of glucose in cancer: a potential therapeutic target.

Authors:  Gustav van Niekerk; Anna-Mart Engelbrecht
Journal:  Cell Oncol (Dordr)       Date:  2018-05-24       Impact factor: 6.730

5.  Shikonin, vitamin K3 and vitamin K5 inhibit multiple glycolytic enzymes in MCF-7 cells.

Authors:  Jing Chen; Xun Hu; Jingjie Cui
Journal:  Oncol Lett       Date:  2018-03-13       Impact factor: 2.967

6.  Hepatic glucose-6-phosphatase-α deficiency leads to metabolic reprogramming in glycogen storage disease type Ia.

Authors:  Jun-Ho Cho; Goo-Young Kim; Brian C Mansfield; Janice Y Chou
Journal:  Biochem Biophys Res Commun       Date:  2018-03-14       Impact factor: 3.575

7.  Adaptive remodeling of skeletal muscle energy metabolism in high-altitude hypoxia: Lessons from AltitudeOmics.

Authors:  Adam J Chicco; Catherine H Le; Erich Gnaiger; Hans C Dreyer; Jonathan B Muyskens; Angelo D'Alessandro; Travis Nemkov; Austin D Hocker; Jessica E Prenni; Lisa M Wolfe; Nathan M Sindt; Andrew T Lovering; Andrew W Subudhi; Robert C Roach
Journal:  J Biol Chem       Date:  2018-03-14       Impact factor: 5.157

8.  Rac1 repression reverses chemoresistance by targeting tumor metabolism.

Authors:  Shanmugasundaram Ganapathy-Kanniappan
Journal:  Cancer Biol Ther       Date:  2020-08-31       Impact factor: 4.742

9.  B-Cell-Specific Diversion of Glucose Carbon Utilization Reveals a Unique Vulnerability in B Cell Malignancies.

Authors:  Gang Xiao; Lai N Chan; Lars Klemm; Daniel Braas; Zhengshan Chen; Huimin Geng; Qiuyi Chen Zhang; Ali Aghajanirefah; Kadriye Nehir Cosgun; Teresa Sadras; Jaewoong Lee; Tamara Mirzapoiazova; Ravi Salgia; Thomas Ernst; Andreas Hochhaus; Hassan Jumaa; Xiaoyan Jiang; David M Weinstock; Thomas G Graeber; Markus Müschen
Journal:  Cell       Date:  2018-03-15       Impact factor: 41.582

Review 10.  Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression.

Authors:  Zhaoyong Li; Huafeng Zhang
Journal:  Cell Mol Life Sci       Date:  2015-10-23       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.